FDA nixes wider use of rheumatoid arthritis drug

Courtesy Newsvine - business  Sat, 10/17/2009 - 09:52

The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.


 

Related items

FDA clears Genentech drug for kidney cancer
Biotech drugmaker Genentech Inc. said Sunday the Food and Drug Administration approved its cancer treatment Avastin for a new use against a form of kidney cancer, marking the sixth approval...

FDA prepares to reassess much-debated knee implant
A medical device company at the center of a controversial approval decision by the Food and Drug Administration is pushing back against the agency's plan to review the implant.

FDA asks for risk plan info on diabetes drug
Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes...

Canon CanoScan 4400F Color Image Scanner (1306B002)
optical resolution: 4800 x 9600 dpi (19,200 x 19,200 dpi interpolated) * 48-bit color depth * scan up to six frames of 35mm film or four mounted slides at a time * high-speed USB interface *...

Plantronics Convert Hands Free Headset with Noise...
-Headset converts from headband to over-the-ear -RF noise shield with adjustable boom -Includes 2.5mm plug -UPC 017229056824


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com